SecBot SecBot
25-NSE ·Filed Jul 27, 2026

AVNS

AVANOS MEDICAL, INC.
NEUTRAL
Impact 5/10
Horizonimmediate Processed3mo ago SEC0000876661-26-000646
Notable filing: 25-NSE
Actionable Insight • Neutral

The merger is complete and the stock is delisted; no further trading in AVNS will occur. Shareholders who have not yet tendered should contact their broker regarding receipt of the $25.00 cash payment. The delisting is a formality with no residual market activity.

DirectionNeutral
Confidencehigh
Horizonimmediate
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The New York Stock Exchange filed a Form 25-NSE to delist Avanos Medical, Inc. (AVNS) following the completion of its going-private merger with A-AV MergerSub, Inc., an affiliate of American Industrial Partners. The merger closed on July 27, 2026, with each share of AVNS common stock converted into $25.00 in cash. Trading was suspended immediately, and delisting will be effective August 7, 2026.

Key Facts

  • Merger closed July 27, 2026; each share of AVNS common stock converted into $25.00 cash.
  • Trading suspended on NYSE as of July 27, 2026; delisting effective August 7, 2026.
  • Acquirer is A-AV MergerSub, Inc., a wholly-owned subsidiary of A-AV Holdco I, Inc., affiliated with investment funds advised by American Industrial Partners.
  • The filing is a procedural notification under Rule 12d2-2(a)(3) for securities that now represent only the right to receive cash.

Financial Impact

All outstanding shares of AVNS were acquired at $25.00 per share in cash, implying a total equity value of approximately $1.2B based on market cap.

share priceequity value

Risk Factors

  • No further trading opportunity; remaining unexchanged shares must be submitted for the cash consideration.
  • Potential delays in receiving cash payment if shareholder records are not updated.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0000876661-26-000646
Document: 0000876661-26-000646-index.html0000876661-26-000646
Document: 0000876661-26-000646.txt0000876661-26-000646

Track record

7 reports on AVNS

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +1.13% at T+60 after the Apr 23, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Jul 27, 202616w ago 25-NSE Neutral 5/10 Viewing Entry $24.99 No price data
  2. Jul 2, 202619w ago 8-K / DEFA14A Bullish 7/10 Entry $24.93 to $24.94 ▲ +0.04% −0.89% vs SPY
  3. Jun 10, 202622w ago DEFM14A Bullish 8/10 Entry $24.98 to $24.87 ▼ −0.44% −0.87% vs SPY
  4. May 5, 202627w ago DEFA14A Neutral 5/10 Entry $24.72 to $24.73 ▲ +0.04% −1.09% vs SPY
  5. Apr 23, 202629w ago DEFA14A Bullish 8/10 Entry $24.71 to $24.65 ▼ −0.24% −1.72% vs SPY
  6. Apr 14, 202630w ago DEFA14A Neutral 4/10 Entry $24.63 to $24.64 ▲ +0.04% −1.35% vs SPY
  7. Feb 26, 202637w ago 8-K Neutral 5/10 Entry $14.49 to $13.79 ▼ −4.83% −3.70% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 27, 2026